Baudax Bio Inc. (BXRX)
NASDAQ: BXRX
· Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM
Baudax Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 326K | 564K | 834K | 1.27M | 1.36M | 1.4M | 1.3M | 1.08M | 756K | 543K | 691K |
Cost of Revenue | 5.34M | 6.51M | 6.77M | 7.01M | 2.79M | 2.05M | 2.27M | 2.44M | 2.41M | 2.49M | 2.55M |
Gross Profit | -5.02M | -5.95M | -5.93M | -5.74M | -1.43M | -644K | -968K | -1.36M | -1.66M | -1.95M | -1.86M |
Operating Income | -22.11M | -3.77M | -3.7M | -11.55M | 27.06M | -5.88M | -15.23M | -19.01M | -65.5M | -36.86M | -50.77M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -25.71M | -53.14M | -53.37M | -58.79M | -20.11M | -7.87M | -15.67M | -19.77M | -66.25M | -37.6M | -52.71M |
Net Income | -7.15M | -34.42M | -34.58M | -58.79M | -20.11M | -7.87M | -15.67M | -19.77M | -66.25M | -37.6M | -52.71M |
Selling & General & Admin | 9.76M | 9.93M | 11.7M | 24.12M | 33.57M | 40.83M | 47.41M | 45.31M | 44.08M | 46.77M | 47.38M |
Research & Development | 7.63M | 6.38M | 5.51M | 3.89M | 3.35M | 3.37M | 3.31M | 3.13M | 5.82M | 6.63M | 7.13M |
Other Expenses | -3M | -2.25M | -1.34M | 2M | 1.93M | 707K | 1.05M | 1.05M | 1.85M | 1.85M | 652K |
Operating Expenses | 17.46M | 17.01M | 18.57M | 30M | 39.49M | 46.77M | 53.3M | 51.01M | 52.48M | 55.98M | 57.08M |
Interest Expense | 921K | 46.18M | 48.83M | 48.83M | 48.49M | 3.23M | 579K | 1.17M | 590K | 590K | 590K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.26M | 2.26M | 2.26M |
Cost & Expenses | 22.25M | 23.01M | 24.93M | 37.01M | 42.29M | 48.82M | 55.57M | 53.46M | 54.89M | 58.46M | 59.63M |
Income Tax Expense | 5.02M | 5.38M | 2.85M | 2.91M | -1.56M | 1.75M | 5.02M | 5.34M | -7.48M | -39.91M | -27.01M |
Shares Outstanding (Basic) | 7.99M | 4.89M | 2.32M | 1.62M | 295.9K | 179.54K | 160.32K | 60.53K | 60.28K | 53.43K | 44.7K |
Shares Outstanding (Diluted) | 7.99M | 4.89M | 2.32M | 1.62M | 295.9K | 179.54K | 160.32K | 60.53K | 60.28K | 53.45K | 44.7K |
EPS (Basic) | -2.54 | -101 | -141.44 | -226.24 | 225.86 | 43.36 | -201.49 | -500 | -1.44K | -259.24 | -2.38K |
EPS (Diluted) | -2.54 | -101 | -141.44 | -226.24 | 180.66 | -1.84 | -247.09 | -545.6 | -1.44K | -287.64 | -2.41K |
EBITDA | -11.49M | -17.48M | -21.16M | -32.19M | -28.41M | -38.76M | -51.31M | -51.93M | -69.05M | -40.41M | -37.5M |
EBIT | -32.01M | -15.96M | -20.84M | -20.74M | 5.52M | -10.54M | -5.66M | 17.93M | -18.91M | -18.91M | -18.91M |
Depreciation & Amortization | 2.05M | 2.6M | 5.94M | -996K | -2.26M | -2.26M | -4.89M | 2.77M | 2.86M | 2.92M | 2.96M |